Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Cord blood transplantation combined with rituximab for Wiskott-Aldrich syndrome with autoimmune thrombotic thrombocytopenic purpura.

Toyoda H, Azuma E, Kawasaki Y, Iwasa T, Ohashi H, Otsuki S, Iwamoto S, Hirayama M, Itoh-Habe N, Wada H, Kondo M, Keida Y, Ito T, Komada Y.

J Allergy Clin Immunol. 2013 Jul;132(1):226-7. doi: 10.1016/j.jaci.2013.01.040. Epub 2013 Mar 14. No abstract available.

PMID:
23498591
2.

A beneficial effect of rituximab on autoimmune thrombotic thrombocytopenic purpura: just a B-cell depletion?

Shin JI, Eisenhut M.

J Allergy Clin Immunol. 2014 Feb;133(2):600. doi: 10.1016/j.jaci.2013.11.022. Epub 2013 Dec 22. No abstract available.

PMID:
24365135
3.

Reply: To PMID 23498591.

Toyoda H, Azuma E.

J Allergy Clin Immunol. 2014 Feb;133(2):600-1. doi: 10.1016/j.jaci.2013.11.023. Epub 2013 Dec 22. No abstract available.

PMID:
24365134
4.

Another beneficial effect of rituximab on refractory and relapsing thrombotic thrombocytopenic purpura: the role of interleukin-12 suppression?

Park SJ, Shin JI.

Crit Care Med. 2012 Apr;40(4):1391. doi: 10.1097/CCM.0b013e318241e3aa. No abstract available.

PMID:
22425862
5.

[Case report; successful treatment with rituximab in a patient with refractory thrombotic thrombocytopenic purpura].

Yoshii Y, Matsumura Y, Boku S, Kamitsuji Y, Yasuda T, Kawase Y, Matsumoto M, Fujimura Y, Uoshima N.

Nihon Naika Gakkai Zasshi. 2013 Jan 10;102(1):147-9. Japanese. No abstract available.

PMID:
23777126
6.

Rituximab for thrombotic thrombocytopenic purpura.

Kivity S, Agmon-Levin N.

Isr Med Assoc J. 2011 Jul;13(7):436-7. No abstract available.

7.

Use of two unrelated umbilical cord stem cell units in stem cell transplantation for Wiskott-Aldrich syndrome.

Slatter MA, Bhattacharya A, Flood TJ, Abinun M, Cant AJ, Gennery AR.

Pediatr Blood Cancer. 2006 Sep;47(3):332-4.

PMID:
16007596
8.

[Response to rituximab in two patients with plasma exchange-refractory thrombotic thrombocytopenic purpura].

Pérez A, Sancho JM, Grífols JR, Ribera JM.

Med Clin (Barc). 2011 Jun 25;137(3):139-40. doi: 10.1016/j.medcli.2010.07.020. Epub 2010 Nov 11. Spanish. No abstract available.

PMID:
21074219
9.

Targeting B cells in severe thrombotic thrombocytopenic purpura--a road to cure?

Kyttaris VC.

Crit Care Med. 2012 Jan;40(1):317-8. doi: 10.1097/CCM.0b013e318232d2b6. No abstract available.

10.

Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center.

Froissart A, Buffet M, Veyradier A, Poullin P, Provôt F, Malot S, Schwarzinger M, Galicier L, Vanhille P, Vernant JP, Bordessoule D, Guidet B, Azoulay E, Mariotte E, Rondeau E, Mira JP, Wynckel A, Clabault K, Choukroun G, Presne C, Pourrat J, Hamidou M, Coppo P; French Thrombotic Microangiopathies Reference Center..

Crit Care Med. 2012 Jan;40(1):104-11. doi: 10.1097/CCM.0b013e31822e9d66.

PMID:
21926591
11.

Efficacy and safety of rituximab in adult patients with idiopathic relapsing or refractory thrombotic thrombocytopenic purpura: results of a Spanish multicenter study.

de la Rubia J, Moscardó F, Gómez MJ, Guardia R, Rodríguez P, Sebrango A, Zamora C, Debén G, Goterris R, López R, Peña F, Pujol M, Vidaller A, Del Río-Garma J, Sanz MA; Grupo Español de Aféresis..

Transfus Apher Sci. 2010 Dec;43(3):299-303. doi: 10.1016/j.transci.2010.09.018. Epub 2010 Oct 12.

PMID:
20934383
12.

[Rituximab for managing refractory thrombotic thrombocytopenic purpura: a report of three cases].

Yamanouchi J, Hato T, Miyoshi K, Kobayashi S, Azuma T, Hasegawa H, Yasukawa M.

Rinsho Ketsueki. 2013 Feb;54(2):205-9. Japanese.

PMID:
23470828
13.

[Efficacy and safety of rituximab therapy for refractory/relapsing thrombotic thrombocytopenic purpura].

Cui J, Zhu TN, Zou N, Chen M, Zhao YQ.

Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2013 Feb;35(1):116-20. doi: 10.3881/j.issn.1000-503X.2013.01.022. Chinese.

14.

Thrombotic thrombocytopenic purpura with severe neurological impairment: remission after Rituximab.

Magalini F, Stella A, Basaglia M, Vescovini R, Sassi M, Maria Lombardi A, Sansoni P.

Transfus Med. 2011 Apr;21(2):140-3. doi: 10.1111/j.1365-3148.2010.01053.x. Epub 2010 Nov 30. No abstract available.

PMID:
21118315
15.

A novel mutation in Wiskott-Aldrich syndrome and successfully treated with umbilical cord blood transplantation.

Zhu X, Tang B, Zheng C, Liu H, Song K, Sun Z.

Blood Cells Mol Dis. 2014 Dec;53(4):283-5. doi: 10.1016/j.bcmd.2014.03.002. Epub 2014 May 11.

PMID:
24824128
16.

Successful unrelated cord blood transplantation in an infant with Wiskott-Aldrich syndrome following recurrent cytomegalovirus disease.

Kaneko M, Watanabe T, Watanabe H, Kimura M, Suzuya H, Okamoto Y, Nakagawa R, Kuroda Y.

Int J Hematol. 2003 Dec;78(5):457-60.

PMID:
14704041
17.

Clinical biological remission induced by rituximab in acute refractory chronic relapsing TTP.

Lombardi AM, de Marinis GB, Scandellari R, Magalini F, Sansoni P, Ballerini PF, Vettore S, Candeo N, Marson P, De Silvestro G, Fabris F.

Thromb Res. 2010 Aug;126(2):e154-6. doi: 10.1016/j.thromres.2010.02.005. Epub 2010 Mar 1. No abstract available.

PMID:
20193960
18.

[Treatment of thrombotic thrombocytopenic purpura with rituximab].

Sui T, Yang RC.

Zhonghua Xue Ye Xue Za Zhi. 2011 Jul;32(7):487-8. Review. Chinese. No abstract available.

PMID:
22213874
19.

Phenotypic and genotypic correction of WASP gene mutation in Wiskott-Aldrich syndrome by unrelated cord blood stem cell transplantation.

Lee YH, Lim YJ, Shin SA, Song CH, Jo EK, Jung JA, Lee HB.

J Korean Med Sci. 2009 Aug;24(4):751-4. doi: 10.3346/jkms.2009.24.4.751. Epub 2009 Jul 30.

20.

[Recent progress of diagnosis and treatment for immune-mediated hematological diseases. Topics: IV. Recent topics; 2. Rituximab for ITP and TTP].

Miyakawa Y.

Nihon Naika Gakkai Zasshi. 2014 Jul 10;103(7):1654-9. Japanese. No abstract available.

PMID:
25154261

Supplemental Content

Support Center